| 产品介绍 | | |
| Mouse anti Human CD33 antibody, clone WM53recognizes the human CD33 cell surface glycoprotein. This antigen, considered to be specific for the myeloid lineage, has also been reported to be present on cells of lymphoid origin.Mouse anti Human CD33 antibody, clone WM53 immunoprecipitates a protein of ~75 kDa from myeloid cells, a smaller protein of approximately 67 kDa has been observed in immunoprecipitates from lymphoid targets. |
| 产品详情 | | |
Target Species | Human |
| Product Form | Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid |
Preparation | Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant |
BufferSolution | Phosphate buffered saline |
Preservative Stabilisers | 0.09% Sodium Azide (NaN3) 1% Bovine Serum Albumin |
| Immunogen | Human AML cells |
| Approx. Protein Concentrations | IgG concentration 0.1 mg/ml |
Fusion Partners | Spleen cells from immunized BALB/c mice were fused with cells of the mouse NSI myeloma cell line |
Max Ex/Em | Fluorophore | Excitation Max (nm) | Emission Max (nm) |
FITC | 490 | 525 |
Regulatory | For research purposes only |
Guarantee | 12 monthsfrom date of despatch |
| 存储条件 | | |
| This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light. |
| 应用 | | |
| Application Name | Verified | Min Dilution | Max Dilution |
Flow Cytometry | √ | | Neat |
| This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications fromthe originators. Please refer to references indicated for further information. For general protocol recommendations, please visit theantibody protocolspage.Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.Use 10ul of the suggested working dilution to label 106cells or 100ul whole blood. |
| 同型 |
| Description | Product Code | Applications | Pack Size |
Mouse IgG1 Negative Control:FITC | MCA928F | F | 100 Tests |
| 相关产品 |
| Description | Product Code | Applications | Pack Size |
| Human Seroblock | BUF070A | F | 50 Test |
| Human Seroblock | BUF070B | F | 200 Test |
| 文献 |
| 1. Lajaunias, F.et al.(2005) Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.Eur J Immunol. 35: 243-51.2. Pietschmann, P.et al.(2000) Surface markers and transendothelial migration of dendritic cells from elderly subjects.Exp Gerontol. 35: 213-24.3. Favaloro, E.J.et al. (1993) Differential expression of surface antigens on activated endothelium.Immunol Cell Biol. 71:571-81.4. Yasukawa, T.et al.(2012) Simple detection of surface antigens on living cells by applying distinct cell positioning with negative dielectrophoresis.Anal Chem. 84 (20): 8830-6.5. Hu, Z.et al.(2016) Self-assembled nanoparticles based on folic acid modified carboxymethyl chitosan conjugated with targeting antibodyJ Wuhan Univ of Technol-Mater. Sci. Ed. 31 (2): 446-53.6. Dahl Cet al.(2004) Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells culturedin vitro.Allergy. 59 (10): 1087-96.7. Vamvakopoulos, J.E. & Green, C. (2003) HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection.BMC Cardiovasc Disord. 3: 6.8. Vamvakopoulos, J.et al.(2002) Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.Eur J Immunol. 32 (10): 2988-96.9. Lin, C.W.et al.(2005) CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.Blood. 106 (10): 3567-74.10. McCormack Eet al.(2013) Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia.Blood. 121 (7): e34-42. |
QQ:1749072012